The Purvalanol A (CDK Inhibitor) market has demonstrated impressive growth, expanding from $0.64 billion in 2025 to $0.7 ...

AI teams are often called fast-moving. The output can be fast, yet the route to reliable outcomes is slower, iterative and full of uncertainty. Agile ...

This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...

A Netherlands dance troupe's breathtaking performance set to Gotye's "Somebody That I Used to Know" is going viral - and it's ...

CDK Modern Retail’s Namu Keys shares strategies for dealers to stay FTC-compliant while enhancing transparency and sales ...

Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today announced ...

Recall visits drive service traffic, boost upsells and build trust, making them a key opportunity for dealership service ...

Social media content that comes out of the sprawling Coachella music festival often looks spontaneous and fun, but many content creators engage in intense levels of planning and strategy weeks ...

Low BMI is associated with tumor progression in patients with HR+/HER– metastatic breast cancer being treated with CDK4/6 ...

KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences WATERTOWN, Mass.

From Godwin Tsa, Abuja The Federal Government has hired a team of 23 lawyers made up of six Senior Advocates of Nigeria (SAN) to defend a suit by a civil society group, Kingdom Human Rights Foundation ...

A Lynchburg man accused of setting a house and vehicles on fire after a dispute faced a judge in court on Friday.